Europe Genotyping Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Genotyping Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Genotyping Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Genotyping Market Regional Analysis

6.2 Europe Genotyping Market Revenue 2021-2031 (US$ Million)

6.3 Europe Genotyping Market Forecast Analysis

7. Europe Genotyping Market Analysis – by Product Type

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Reagents and Kits

7.2.1 Overview
7.2.2 Reagents and Kits: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Bioinformatics

7.3.1 Overview
7.3.2 Bioinformatics: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Genotyping Services

7.4.1 Overview
7.4.2 Genotyping Services: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Genotyping Market Analysis – by Technology

8.1 Microarray

8.1.1 Overview
8.1.2 Microarray: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Capillary Electrophoresis

8.2.1 Overview
8.2.2 Capillary Electrophoresis: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Sequencing

8.3.1 Overview
8.3.2 Sequencing: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Polymerase Chain Reaction

8.4.1 Overview
8.4.2 Polymerase Chain Reaction: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Matrix-Assisted Laser Desorption / MALDI-TOF

8.5.1 Overview
8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Other Technologies

8.6.1 Overview
8.6.2 Other Technologies: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Genotyping Market Analysis – by Application

9.1 Pharmacogenomics

9.1.1 Overview
9.1.2 Pharmacogenomics: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Diagnostics and Personalized Medicine

9.2.1 Overview
9.2.2 Diagnostics and Personalized Medicine: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Animal Genetics

9.3.1 Overview
9.3.2 Animal Genetics: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.4 Agricultural Biotechnology

9.4.1 Overview
9.4.2 Agricultural Biotechnology: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.5 Other Applications

9.5.1 Overview
9.5.2 Other Applications: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Genotyping Market Analysis – by End user

10.1 Pharmaceutical and Biopharmaceutical Companies

10.1.1 Overview
10.1.2 Pharmaceutical and Biopharmaceutical Companies: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Diagnostic and Research Laboratories

10.2.1 Overview
10.2.2 Diagnostic and Research Laboratories: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Academic Institutes

10.3.1 Overview
10.3.2 Academic Institutes: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Other End Users

10.4.1 Overview
10.4.2 Other End Users: Europe Genotyping Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Genotyping Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Genotyping Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 Europe Genotyping Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 UK: Europe Genotyping Market Breakdown, by Product Type
11.2.1.1.2 UK: Europe Genotyping Market Breakdown, by Technology
11.2.1.1.3 UK: Europe Genotyping Market Breakdown, by Application
11.2.1.1.4 UK: Europe Genotyping Market Breakdown, by End user

11.2.1.2 Germany: Europe Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Germany: Europe Genotyping Market Breakdown, by Product Type
11.2.1.2.2 Germany: Europe Genotyping Market Breakdown, by Technology
11.2.1.2.3 Germany: Europe Genotyping Market Breakdown, by Application
11.2.1.2.4 Germany: Europe Genotyping Market Breakdown, by End user

11.2.1.3 France: Europe Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 France: Europe Genotyping Market Breakdown, by Product Type
11.2.1.3.2 France: Europe Genotyping Market Breakdown, by Technology
11.2.1.3.3 France: Europe Genotyping Market Breakdown, by Application
11.2.1.3.4 France: Europe Genotyping Market Breakdown, by End user

11.2.1.4 Russia: Europe Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Russia: Europe Genotyping Market Breakdown, by Product Type
11.2.1.4.2 Russia: Europe Genotyping Market Breakdown, by Technology
11.2.1.4.3 Russia: Europe Genotyping Market Breakdown, by Application
11.2.1.4.4 Russia: Europe Genotyping Market Breakdown, by End user

11.2.1.5 Italy: Europe Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Italy: Europe Genotyping Market Breakdown, by Product Type
11.2.1.5.2 Italy: Europe Genotyping Market Breakdown, by Technology
11.2.1.5.3 Italy: Europe Genotyping Market Breakdown, by Application
11.2.1.5.4 Italy: Europe Genotyping Market Breakdown, by End user

11.2.1.6 Rest of Europe: Europe Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Genotyping Market Breakdown, by Product Type
11.2.1.6.2 Rest of Europe: Europe Genotyping Market Breakdown, by Technology
11.2.1.6.3 Rest of Europe: Europe Genotyping Market Breakdown, by Application
11.2.1.6.4 Rest of Europe: Europe Genotyping Market Breakdown, by End user

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Hoffmann-La Roche Ltd.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 QIAGEN NV.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Merck KGaA.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 EUROFINS GENOMICS.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Thermo Fisher Scientific Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 BioTek Instruments, Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Illumina Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Danaher Corp.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Bio-Rad Laboratories Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 GE HealthCare Technologies Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Standard BioTools Inc.

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 Laboratory Corp of America Holdings.

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

14.13 Beckman Coulter Inc.

14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments

14.14 BGI.

14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments

14.15 Takara Bio Inc.

14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments

14.16 DiaSorin SpA.

14.16.1 Key Facts
14.16.2 Business Description
14.16.3 Products and Services
14.16.4 Financial Overview
14.16.5 SWOT Analysis
14.16.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Genotyping Market